BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24769442)

  • 21. A protein kinase Cdelta-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestos.
    Buder-Hoffmann SA; Shukla A; Barrett TF; MacPherson MB; Lounsbury KM; Mossman BT
    Am J Pathol; 2009 Feb; 174(2):449-59. PubMed ID: 19116364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.
    Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR
    Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
    Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
    Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular signal-regulated kinase activation by Neisseria gonorrhoeae downregulates epithelial cell proapoptotic proteins Bad and Bim.
    Howie HL; Shiflett SL; So M
    Infect Immun; 2008 Jun; 76(6):2715-21. PubMed ID: 18391004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.
    Zhang W; Konopleva M; Burks JK; Dywer KC; Schober WD; Yang JY; McQueen TJ; Hung MC; Andreeff M
    Cancer Res; 2010 Mar; 70(6):2424-34. PubMed ID: 20215498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
    Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
    Chetoui N; Boisvert M; Gendron S; Aoudjit F
    Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.
    Adachi Y; Watanabe K; Kita K; Kitai H; Kotani H; Sato Y; Inase N; Yano S; Ebi H
    Carcinogenesis; 2017 Oct; 38(11):1063-1072. PubMed ID: 28968756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism.
    Zaanan A; Okamoto K; Kawakami H; Khazaie K; Huang S; Sinicrope FA
    J Biol Chem; 2015 Sep; 290(39):23838-49. PubMed ID: 26245900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication.
    Mayank AK; Sharma S; Nailwal H; Lal SK
    Cell Death Dis; 2015 Dec; 6(12):e2018. PubMed ID: 26673663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD70-driven costimulation induces survival or Fas-mediated apoptosis of T cells depending on antigenic load.
    Wensveen FM; Unger PP; Kragten NA; Derks IA; ten Brinke A; Arens R; van Lier RA; Eldering E; van Gisbergen KP
    J Immunol; 2012 May; 188(9):4256-67. PubMed ID: 22450812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells.
    Chen K; Tu Y; Zhang Y; Blair HC; Zhang L; Wu C
    J Biol Chem; 2008 Feb; 283(5):2508-17. PubMed ID: 18063582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
    Craxton A; Draves KE; Gruppi A; Clark EA
    J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.
    Wert MM; Palfrey HC
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim.
    Kurtulus S; Tripathi P; Moreno-Fernandez ME; Sholl A; Katz JD; Grimes HL; Hildeman DA
    J Immunol; 2011 May; 186(10):5729-37. PubMed ID: 21451108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bim protein degradation contributes to cisplatin resistance.
    Wang J; Zhou JY; Wu GS
    J Biol Chem; 2011 Jun; 286(25):22384-92. PubMed ID: 21561860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM.
    Rambal AA; Panaguiton ZL; Kramer L; Grant S; Harada H
    Leukemia; 2009 Oct; 23(10):1744-54. PubMed ID: 19404317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung.
    Qian J; Zou Y; Rahman JS; Lu B; Massion PP
    Mol Cancer Ther; 2009 Jan; 8(1):101-9. PubMed ID: 19139118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERK acts in parallel to PKCδ to mediate the connexin43-dependent potentiation of Runx2 activity by FGF2 in MC3T3 osteoblasts.
    Niger C; Buo AM; Hebert C; Duggan BT; Williams MS; Stains JP
    Am J Physiol Cell Physiol; 2012 Apr; 302(7):C1035-44. PubMed ID: 22277757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells.
    Hazlehurst LA; Argilagos RF; Dalton WS
    Br J Haematol; 2007 Jan; 136(2):269-75. PubMed ID: 17233818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.